Role of Antinuclear Antibodies in Experimental and Clinical Liver Transplantation

Transplantation Proceedings

Volumn 38, Issue 10, 2006, Pages 3605-3606

  Nakano, T ^a   Lai, C Y ^a   Goto, S ^a   Hsu, L W ^a   Lin, Y C ^a   Kao, Y H ^a   Kawamoto, S ^a   Chiang, K C ^a   Ohmori, N ^a   Goto, T ^a   Sato, S ^a   Ono, K ^a   Jawan, B ^a   Cheng, Y F ^a   Chen, C L ^a  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY; CYCLOSPORIN A; HIGH MOBILITY GROUP B1 PROTEIN; HISTONE ANTIBODY; HISTONE H1;

ACUTE GRAFT REJECTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; DISEASE MARKER; DRUG WITHDRAWAL; HIGH MOBILITY GROUP BOX DOMAIN; HUMAN; IMMUNOLOGICAL TOLERANCE; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; NONHUMAN; ORTHOTOPIC TRANSPLANTATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RAT STRAIN;

ANIMALS; ANTIBODIES, ANTINUCLEAR; AUTOANTIBODIES; DISEASE MODELS, ANIMAL; HUMANS; IMMUNE TOLERANCE; LIVER TRANSPLANTATION; RATS; RATS, INBRED LEW;

EID: 33845461537     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2006.10.076     Document Type: Article

References (6)

1. Nakano T., Kawamoto S., Lai C.Y., et al. Liver transplantation-induced antihistone H1 autoantibodies suppress mixed lymphocyte reaction. Transplantation 77 (2004) 1595
2. Nakano T., Kawamoto S., Lai C.Y., et al. Characterization of immunosuppressive factors expressed in serum by rat tolerogenic liver transplantation. Transplant Proc 37 (2005) 80
3. Lotze M.T., and Tracey K.J. High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal. Nat Rev Immunol 5 (2005) 331
4. Kamada N., and Calne R.Y. Orthotopic liver transplantation in the rat. Technique using cuff for portal vein anastomosis and biliary drainage. Transplantation 28 (1979) 47
5. Dumitriu I.E., Baruah P., Valentinis B., et al. Release of high mobility group box 1 by dendritic cells controls T cell activation via the receptor for advanced glycation end products. J Immunol 174 (2005) 7506
6. Hsu L.W., Goto S., Nakano T., et al. The effects of anti-histone H1 antibody on immune cells responsible for rejection reaction. Mol Immunol 42 (2005) 1155